Filter
622
Filtered Results: 622
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
55
New Publications
192
Language
Document type
No document type
330
Studies & Reports
110
Guidelines
84
Strategic & Response Plan
39
Manuals
37
Training Material
8
Fact sheets
8
Situation Updates
4
Resource Platforms
2
Countries / Regions
India
35
Global
31
Ethiopia
27
Kenya
26
Uganda
16
South Africa
14
Liberia
11
Nepal
11
Tanzania
11
Western and Central Europe
11
Sierra Leone
10
Nigeria
10
Zambia
9
Namibia
9
Ghana
8
Philippines
8
Rwanda
7
Bangladesh
7
Ukraine
7
Zimbabwe
6
Indonesia
6
Africa
6
South Sudan
5
Syria
5
Myanmar / Burma
5
Congo, Democratic Republic of
4
Cambodia
4
Malawi
4
Lesotho
4
Eastern Europe and Central Asia
4
Senegal
3
Cameroon
3
Eswatini/ Swaziland
3
West and Central Africa
3
South–East Asia Region
3
Eastern Europe
3
Burkina Faso
2
Pakistan
2
Jordan
2
Thailand
2
Mozambique
2
Botswana
2
East and Southern Africa
2
Latin America and the Carribbean
2
Fiji
2
Laos
2
Vietnam
2
Guinea
1
Mali
1
USA
1
Haiti
1
Somalia
1
Iraq
1
Lebanon
1
Egypt
1
Sudan
1
Benin
1
Central African Republic
1
Brazil
1
Libya
1
Yemen
1
Middle East and North Africa
1
Albania
1
Southern Africa
1
Timor Leste/ East Timor
1
Lithuania
1
Moldova
1
Iran
1
Australia
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
266
Clinical Guidelines
35
Key Resources
31
Public Health
29
Women & Child Health
17
Pharmacy & Technologies
8
Capacity Building
7
Toolboxes
Pharmacy
56
AMR
50
COVID-19
30
HIV
29
Mental Health
28
Planetary Health
27
TB
26
NTDs
25
Rapid Response
17
Conflict
13
NCDs
12
Health Financing Toolbox
11
Caregiver
10
Ebola
9
Global Health Education
8
Specific Hazards
6
Disability
4
Natural Hazards
3
Refugee
3
Social Ethics
2
Health Financing
2
South Sudan
1
Zika
1
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, tre...
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and mole...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative ...
Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | This consensus document on Management of Gallbladder cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and...
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supporti...
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer ...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and ... of CVD diseases. Affordable essential medicines and technologies to manage CVD disease must be available where and when they are required. Medicines and technologies need to be managed appropriately to ensure that the correct medicines are selected, procured in the right quantities, distributed to facilities in a timely manner, and handled and stored in a way that maintains their quality. This needs to be backed up by policies that enable sufficient quantities to be procured in order to reduce cost inefficiencies, ensure the reliability and security of the distribution system, and encourage the appropriate use of these health products. In order to avoid stock-outs and the disruption of treatment, all related activities need to be conducted in a timely manner, with performance continually monitored, and prompt action taken in response to problems that may arise. Additionally, medication must be dispensed correctly and used rationally by the healthcare provider and patient alike. The purpose of this guide is to explain the necessary steps.
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies ...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effectiv...
USAID funded/ Primary Health Care Project in Iraq (PHCPI) in cooperation with Iraqi Ministry of Health (MOH) aims to promote Primary Health Care (PHC) services provided by Primary Health Care Clinics (PHCCs) in Iraq in order to achieve the development goal in enhancing the PHC provision system throu...
